%0 Case Reports
%T Complete remission of rare adenocarcinoma of the oropharynx with APCEDEN® (dendritic cell-based vaccine): a case report.
%A Kumar C
%A Kohli S
%A Chiliveru S
%A Jain M
%A Sharan B
%J Clin Case Rep
%V 5
%N 10
%D 10 2017
%M 29026574
暂无%R 10.1002/ccr3.1169
%X APCEDEN ® is an autologous monocyte-derived dendritic cell-based immunotherapy. A 58-year-old man with adenocarcinoma of oropharynx shows complete remission after receiving APCEDEN ® in conjunction with Geftinib validated by reduction in size, whereas Gefitinib alone lead to disease progression.